WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2001034808) METHOD OF LARGE-SCALE PRODUCTION AND METHOD OF TESTING OF THE BIOLOGICAL ACTIVITY OF A SUBSTANCE FROM SOYBEAN
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2001/034808    International Application No.:    PCT/US2000/031211
Publication Date: 17.05.2001 International Filing Date: 12.11.2000
Chapter 2 Demand Filed:    04.06.2001    
IPC:
C07K 14/415 (2006.01), C12P 21/00 (2006.01)
Applicants: FILGEN BIOSCIENCES, INC. [US/US]; 2333 Courage Drive, Fairfield, CA 94533 (US)
Inventors: GALVEZ, Alfredo, F.; (US)
Agent: PETERS, Howard; Peters, Verny, Jones & Biksa, LLP, Suite 6, 385 Sherman Avenue, Palo Alto, CA 94306 (US)
Priority Data:
60/165,334 12.11.1999 US
Title (EN) METHOD OF LARGE-SCALE PRODUCTION AND METHOD OF TESTING OF THE BIOLOGICAL ACTIVITY OF A SUBSTANCE FROM SOYBEAN
(FR) PROCEDE DE PRODUCTION A GRANDE ECHELLE ET METHODE D'ANALYSE DE L'ACTIVITE BIOLOGIQUE D'UNE SUBSTANCE PROVENANT DU SOJA
Abstract: front page image
(EN)The lunasin peptide has been shown to exhibit inhibitory effects against malignant transformation of cells induced by chemical carcinogens and viral oncogenes. The present invention relates to a method for large-scale production of lunasin using recombinant DNA technology. The invention also includes a method for a rapid, in vitro transformation assay to detect and quantify the biological activity of this cancer preventive peptide.
(FR)On a découvert que le peptide de lunasine possédait des effets inhibiteurs des transformations cellulaires malignes induites par des carcinogènes chimiques et des oncogènes viraux. L'invention concerne un procédé de production de lunasine à grande échelle à l'aide de techniques de recombinaison d'ADN. L'invention concerne également une méthode rapide d'analyse de transformations in vitro; afin de détecter et de quantifier l'activité biologique de ce peptide de prévention du cancer.
Designated States: AE, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CR, CU, CZ, DE, DK, DM, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)